Mark R. Pittelkow

Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

Elise A. Olsen, Eric C. Vonderheid, Nicola Pimpinelli et al. · Blood · 2007 · 1.4K citations

Production and auto-induction of transforming growth factor-α in human keratinocytes

Robert J. Coffey, Rik Derynck, Josiah N. Wilcox et al. · Nature · 1987 · 863 citations

Regenerative Medicine, Skin Development, Human Growth +9

Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

Elise A. Olsen, Sean Whittaker, Youn H. Kim et al. · Journal of Clinical Oncology · 2011 · 641 citations · Full text

Immunodeficiencies, Immunology, Clinical End Points +17

Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium.

Gary D. Shipley, Mark R. Pittelkow, John J. Wille et al. · PubMed · 1986 · 555 citations

Human Growth, Tgf Beta/gi, Cell Proliferation +17

Overexpression of Transforming Growth Factor α in Psoriatic Epidermis

James T. Elder, Gary J. Fisher, Patricia B. Lindquist et al. · Science · 1989 · 537 citations